91

Literatur "Coenzym Q10"

1. Appelkvist EL; Kalen A; Dallner G: Biosynthesis and regulation of coenzyme Q10 . Biomed.and Clin.Aspects of
Q10: 6:141-150 (1991)
2. Atar D; Mortensen SA; Flachs H; Herzog WR: Coenzym Q10 protects ischemic myocardium in an open-chest
swine model. Clin. Investig. 71:103-11 (1993)

3. Baggio E; Gardini R; Plancher AC; Passeri M; Carmosimo G: Italian multicenter study on the safety and efficiency of Coenzyme Q10 as adjunctive therapy in heart failure. Mol Aspects Med : 15s:287-294 (1994)
4. Battino M; Ferri E; Gattavecchia E; Sassi S; Lenaz G: Coenzym Q10 as a possible membrane protecting agent against irradiation damages. Biomed.and Clin.Aspects of Coenzym Q . Folkers K; Yamagami T; Littaru GP: Eds. Elsevier Vol. 6:181-190 (1991)
5. Baynes IW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-12 (1991)

6. Beal et al.: Coenzym Q10 and nicotinamide block stria- tal lesions producted by the mitochondrial toxin malonat. Annals of Neurology , Vol. 36, No.6 pp. 882-888 (1994)

7. Beal FM: Coenzyme Q10 as a potential treatment for neurodegenerative diseases. Boston : 1 st Conf.of the Intl. Coenzyme Q10 Assn. : 52-53 (1998)

8. Beal FM: Neuroprotective effects of CoQ in models of neurodegen. diseases. 9th Intl.Symp.Biomed.and Clin. Aspects of Coenzyme Q : 9:30-32 (1996)

9. Bishop JM: Krebsgene. Spektrum der Wissenschaft 1982; Mai: 44-56

10. Bishop J.M: The molecul. genetics of cancer. Science 1987; 235:305-311

11. Bliznakov EG; Hunt GL: Die Entdeckung: Energie-Vitamin Q10 . Lebensbaum-Verlag, Bielefeld

12. Bresolin N; Moroni I; Angelini C; Doriguzzi C; Ca- stelli E; Licciardello L; Carenzi A; Banfi P; Comi G; Scar- lato G: Ubidecarenone treatment in 50 patients with mitochondrial myopathies: the first double blind trial. Biomed.and Clin.Aspects of CoQ10: 6:397-405 (1991)

13. Brodeur GM; Seeger RC: Gene amplification in human neuroblastomas: basic mechanisms and clinical implications. Cancer Genet. Cytogenet. (1986) 19:101-111

14. Brouillet E et al .: Aminooxyacetic acid striatal lesions attenuated by 1,3-butamediol and coenzyme Q10. Neurosci. Lett . 177, 58-62 (1994)

15. Brunzell JD; Tsai EC; Chait A: Reduced plasma free radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled insuline-dependent diabetes mellitus.Dabetes 43; 1010-1014 (1994)
16. Busciglio J; Yankner BA: Apoptosis and increased generation of reactive oxygen species in Down´s syndrome neurons in vitro. Nature, Vol 378, 776-779 (1995)
17. Cahn J; Borzeix MG: The effect of ubichinone 50 over the subacute phase of an experimental stroke in the rat: Biomed.and Clin.Aspects of Coenzym Q , Volume 4, Elsevier Science Publishers B.V. (1984)

18. Cameron NE; Coffer MA; Archibald V; Dine KC; Maxfield EK: Antioxidant and prooxidant effects on nerve conduction velocity, endoneural blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37 : 449-459 (1994)

19. Chello M; Mastroroberto P; Romano R; Bevaqua E; Pantaleo D; Ascione R; Marchese AR; Spampinato N: Protecting by coenzyme Q10 from myocardial reperfusion injury during coronary artery bypass grafting . Ann Thorac Surg: 58:5:1427-1432 (1994)

20. Chello M; Mastroroberto P; Romano R; Castaldo P; Bevaqua E; Marchese AR: Protecting by coenzyme Q10 of tissue reperfusion injury during abdominal aortic cross-clamping. J Cardiovasc Surg: 37:229-235 (1996)

21. Crane FL; Sun IL; Sun EE: The essential functions of coenzym Q 10. Clin.Investig: 71:55-59 (1993)

22. Cross SHS; Peterlik M: Zellmembran und Zellkern: Funktionelle Pathologie: molekulare-zelluläre-systemati- sche Grundlagen. Wick, G; Schwarz S; Förster O; Peterlik M: Gustav Fischer Verlag Stuttgart, New York (1989)
22. Csordas A.: DNS-Reparatur: Funktionelle Pathologie :molekulare-zelluläre-systematische Grundlagen. Wick G; Schwarz S; Förster O; Perlik M: Gustav Fischer Verlag Stuttgart, New York (1989)

23. Daneryd P; Aberg F; Dallner G; Ernster L; Schersten T; Soussi B: Coenzyms Q9 and Q10 in skeletal and cardiac muscle in tumor-bearing exercising rats. Eur.J.Can- cer (1995) 31A, 5:760-765

24. Diamant B; Karlsson J:Ubikinon-kolesterolets ukend- te soster. Biosynth., biologiske virkninger og terap. muligheder. Ugeskr Laeger: 152:45:3365-67 (1990)

25. Diggory P; Cassels-Brown A; Vail A; Abbey LM; Hillmann JS; Avoiding unsuspected respiratory side-effects of topical timolol cardioselective or sympathomimetic agents. The Lancet (1995) 345:1604-1606

26. Digiesi V; Cantini F; Oradei A; Bisi G et al.: Coenzyme Q10 in essential hypertension . 8 th Int.Symp. Biomed.and Clin.Aspects of CoQ10: 44 (1993) and Mol Aspects Med : 15s:257-263 (1994)

27. Ernster L:Ubiquinone: redox-enzyme, hydrogen carrier, antioxidant. Biomed.and Clin.Aspects of CoQ10 : 4:3-14 (1984)

28. Ernster L; Beyer RE: Antioxidant functions of coenzyme Q: some biochemical and pathophysiological implications. Biomed. and Clin.Aspects of CoQ10 : 6:45-58 (1991)

29. Felber JP; Golay A; Jéguier: Institut de Physiologie à l’Université de Lausanne. Switzerland: Insulin resistance in aging. Relationship with a relative increase in lipid oxidation . Meeting of the European Diabetes Association. Abstract 261, (1993)

30. Flier JS; Lowell BB; Susulic VS; Hamann AJ; Lawitt JA; Himms-Hagen J; Boyer BB; Kozak LP: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: 740-742, (1993)

31. Folkers K: Critique of 30 years of research on hematopoietic and immunological activities of coenzyme Q10 potentiality for the rapy of aids and cancer. Med Chem Res: 2:48-60 (1992)

32. Folkers K: Heart failure is a dominant deficiency of coenzyme Q10 and challenges for future clinical research on CoQ10. Clin Investig : 71:51-54 (1993)

33. Folkers K; Brown R; Hanioka T; Williams M et al.: Involvement of deficiency of coenzyme Q10 in cancer therapy and blood levels of CoQ10 in cancer patients in America. Proc Natl Acad Sci (1993)

34. Folkers K; Brown R; Judy WV; Morita M: Survival of cancer patients on therapy with coenzyme Q10 . Biochem Biophys Res Commun : 192:1:241-5 (1993)

35. Folkers K; Nylander M; Morita M: Involvement of a deficiency of CoQ10 in cancer therapy and blood levels of CoQ10 in cancer patients in Sweden. Proc Natl Acad Sci (1993)

36. Folkers K; Simonsen R: Two succesful double-blind trials with coenzyme Q10 on muscular dystrophies and neurogen. Atrophies. Biochim Biophys Acta: 1271:1:281 -286 (1995)

37. Folkers K; Vadhanavikit S; Mortensen SA: Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10 . Proc Natl Acad Sci USA : 82:3:901-904 (1985)

38. Folkers K; Wolaniuk J: Restoration of impaired cardiac function of patients with diverse muscular dystrophies by therapy with CoQ10. US Patent 4,885,167: 1-10 (1989)

39. Folkers K; Wolaniuk J; Simonsen R; Lyson K et al: Therapy with coenzyme Q10 for muscular dystrophies and neurogenic atrophies by double blind trial . Biomed. and Clin.Aspects of CoQ10: 5:353-358 (1986)

40. Folkers K; Brown R; Hanioka T; Williams M; Quillin P; Jafelice R: Involvement of a deficiency of coenzym Q10 in cancer therapy and blood levels of Co Q10 in cancer patients in America. Proc.Nat.Acad.Sci.USA (1993) (submitted)

41. Folkers K; Brown R; Judy WV; Morita M: Survival of cancer patients on therapy with coenzym Q10. Res. Commun.Biochem.Biophys. (1993) 192, 1:241-245.

42. Folkers K; Shizukuishi S; Takemura K; Drzewoski J; Richardson, P., Ellis, J., Kuzell, W.: Increase in levels of Ig G in serum of patients treated with coenzym Q10. Res. Commun.Chem.Path.Pharm. (1982) 38, 2:335-338.

43. Fujimoto S; Kurihara N; Hirata K; Takeda T: Effects of coenzyme Q10 administration on pulmonary function and exercise performance in patients with chronic lung diseases. Clin Investig: 71:162-166 (1993)

44. Ghirlanda G; Oradei A; Manto A; Lippa S et al: Evidence of plasma CoQ10-lowering effect by HMG-CoA-reductase inhibitors. A double-blind, placebo-controlled study: J Clin Parmacol : 33:3:226-229 (1993)

45. Gvozdjakova A; Kucharsk J; Lepiés P; Braunow Z; Malatinsky E: Decreased level of sperm coenzyme Q10 mitochondrial respiration and energy production in infertile patients: therapeutic effect of coenzyme Q10 . 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 137-138 (1998)

46. Gvozdjakova A; Kucharsk J; Nraunov Z; Koles P: Benificial effect of CoQ10 on the antioxidative status and metabolism of fats and sugars in diabetic patients. Boston : 1st Conf. of the Intl. Coenzyme Q10 Assn.: 95-97 (1998)

47. Hanioka T; Shizukuishi S; Folkers K: Effect of topical application of coenzyme Q10 on adult periodontitis. 8th Int.Symp.Biomed.and Clin.Aspects of CoQ10: 38-39 (1993)

48. Hanioka T; Tanaka M; Ojima M; Shizukuishi S: Effect of topical application of coenzyme Q10 an adult periodontitis. Mol Aspects Med: 15s:241-248 (1994)

49. Hiasa Y; Ishida T; Maeda T; Iwano K et al.: Effects of coenzyme Q10 on exercise tolerance in patients with stable angina pectoris . Biomed.and Clin.Aspects of Q10: 4:291-302 (1984)

50. Hofmann-Bang C; Rehnquist N; Swedberg K; Wiklund I; Aström H: Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure . Journal of Cardiac Failure: 1:2:101-107 (1995)

51. Hogenauer G; Mayer P; Drews J: The macrophage activating potential of ubiquinones. Biochem. and Clinical Aspects of Coenzym Q . Folkers, K., Yamagami, T., Littaru, G.P.: Eds. Elsevier (1981) Vol. 3:325-334

52. Hoppe U: Coenzyme Q10: a cutaneous antioxidant and energizer. Boston: 1 st Conf.of the Intl.Coenzyme Q10 Assn.: 83 (1998)

53. Höpping W: Diagnose und Therapie des Retinobla- stoms. Essener Unikate (1992) 1:59-69

54. Horio F; Fukuda M; Katoh H; Peturzelli; Yano N; Rittershoms C; Borner-Weiler S; Hattori M: Role of oxidative stress in development of complications in diabetes. Diabetologia 37:22-31 (1994)

55. Horsting MWIM; Strijks E: Q10 therapy in patients with Parkinson´s disease. 9th Intl.Symp.Biomed. and Clin. Aspects of CoQ10 9:58 (1996)

56. Hübner C et al.: Decreased plasma ubiquin.-10 concentration in patients with mevalonate kinase deficiency. Pediatr. Res . 34: 129-133 (1993)

57. Iarussi D; Auricchio U; Agretto A; Murano A; Giuliano M; Indolfi P; Iacono A: Protective effect of Coenzym Q10 on anthracyclines cardiotoxicity: Control study in children with acute lymphoblastic leukemia and non-hodgkin-lymphoma. Molec.Aspects Med: 15 : 207-212 (1994)

58. Ihse I; Andren-Sandberg A; Nylander M; Folkers K: Research on an deficiency of coenzyme Q10 in cancer patients and initiation of treatment with CoQ10 . 8 th Int. Symp.Biomed. and Clin.Aspects of CoQ10 : 48 (1993)

59. Jameson S: Statistical Data Support Prediction of Death within Six Months on Low Levels of Coenzyme Q10 and Other Entities. Clin.Investig: 71:S137-9 (1993)

60. J udy WV; Folkers K: Management of chronic fatigue syndrome patients with CoQ10 . 8 th Int.Symp. Biomed. and Clin.Aspects of CoQ10: 55 (1993)

61. Judy WV; Stogsdill WW; Folkers K: Dose related effectiveness of coenzyme Q10 in the treatment of chronic fatigue. Boston: 1 st Conf.of the Intl.Coenzyme Q10 Assn.: 86 (1998)

62. Judy WV; Stogsdill WW; Folkers K: Myocardial Preservation by Therapy With Coenzyme Q10 During Heart Surgery. Clin.Investig: 71:S155-61 (1993)

63. Judy WV; Willis RA; Folkers K: Regression of prostate cancer and plasma specific antigens (PSA) in patients on treatment with CoQ10. Boston : 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 143 (1998)

64. Judy WV; Stogsdill WW; Folkers K: Myocardial preservation by therapy with coenzym Q10 during heart surgery. Clin.Investig. 71:155-161 (1993)

65. Kagan V; Serbinova E; Packer L: Antioxidant effect of ubiquinones in microsomes and mitochondria are mediated by tocoph. Recycling. Biochem.Biophys.Res.Com- mun 169: 851-857 (1990)

66. Kähler W; Kuklinki B; Rühlmann C; Plötz C: Diabetes mellitus - eine mit Freien Radikalen assoziierte Erkrankung. Resultate einer adjuvanten Antioxidantiensupplementation. Gesamte Inn Med: 48:5:223-32 (1993)

67. Kalen A: in Bliznakov EG; Hunt GL : Die Entdeckung: Energie-Vitamin Q10 . Lebensbaum-Verlag

68. Kamei M; Fujita T; Kanbe T; Sasaki K; Oshiba K; Otami S; Matsui-Yuasa I; Morisawa S: The distribution and content of ubiquinone in foods. Int J Vitam Nutr Res: 56:1:57-63 (1986)

69. Karlson J; Diamant B; Theorell H; Folkers K: Skeletal muscle coenzyme Q10 in healthy men and selected patient groups. Biomed. and Clin. Aspects of Q10: 6:191-204 (1991)

70. Kawasaki T; Sugino K; Marubayashi S: The role of cellular antioxidants and of administered Q10 in oxidative cellular damage. Biomed.and Clin.Aspects of CoQ10: 5:145 -156 (1986)

71. Kelly K: Growth factors short-circuited. Nature 317: 390 (1985)

72. Keogh A; Fenton S; Leslie C; Stocker R; Aboyoun C; MacDonald P; Martin A: Coenzyme Q10 in class II and III dilated cardiomyopathie. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 112-113 (1998)

73. Kishi T; Takahashi K; Mayumi T; Hama T: Protective effect of coenzyme Q on adriamycin in beating heart cells. Biomed. and Clin. Aspects of CoQ10: 4:181-194 (1984)

74. Kishi T; Okamoto T; Takahashi T; Goshima K; Yamagami T: Cardiostimulatory action of coenzyme Q homologues on cultered myocardial cells and their biochemical mechanisms. Clin. Investig . 71:71-75 (1993)

75. Kontush A; Hübner C; Finckh B; Kohlschütter A et al: Supplementation with ubiquinol-10 protects low density lipoprotein against lipid peroxidation more efficiently than supplementation with alpha-tocopherol. 8th Int.Symp. Biomed. and Clin.Aspects of CoQ10: 68 (1993)

76. Kontush A; Hübner C; Finckh B; Kohlschütter A; Beisiegel U: Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. Biochim Biophys Acta: 1258:2:177-187 (1995)

77. Koroshetz WJ et al., (1996) Assesment of energy metabolism defects in Huntington´s disease and possible therapy with coenzym Q10. Ann. Neurol . In press

78. Koroshetz WJ; et al., Energy metabolism defects in Huntington´s disease and effects of Coenzym Q10. Ann. Neurol. 41:160-165 (1997)

79. Krämer K: Antioxidanzien in der Onkologie. Dtsch. Zschr. Onkol. 26, 3:76-83. (1994)

80. Kuklinsky B; van Lunteren I: Neue Chancen zur natürlichen Vorbeugung und Behandlung von umweltbedingten Krankheiten - Zellschutz mit Anti-Oxidantien. Lebensbaum-Verlag, Bielefeld (1995)

81. Lampertico M; Comis S: Italian Multicenter Study on the Efficiency and Safety of CoQ10 as Adjuvant Therapy in Heart Failure. Clin Investig : 71:S129-133 (1993)

82. Landi L; Pasquali P; Bassi P; Cabrini L; Effect of oxygen free radicals on ubiquinone in aqueous solution and phospholipid vesicals. Biochem. Biophys. Acta 902: 200-206 (1987)

83. Langsjoen H; Langsjoen P; Willis R; Folkers K; Langsjoen P: Usefulness of coenzyme Q10 in clinical cardiology: A long-term study. Mol Aspects Med: 15s: 165-175 (1994)

84. Langsjoen P., Langsjoen, P., Willis, R., Folkers, K.: Treatment of essential hypertension with coenzym Q10. Molec.Aspects: 15 (Supplement): 265-272 (1994)

85. Langsjoen PH; Folkers K: Long-term efficiency and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol: 65:7:521-3 (1990)

86. Langsjoen PH; Langsjoen AM: Overview of the use of CoQ10 in cardiovascular disease. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 56-57 (1998)

87. Langsjoen PH; Langsjoen PH; Folkers K: A six-year clinical study of therapy of cardiomyopathie with coenzyme Q10. Int J Tissue React: 12:3:169-171 (1990)

88. Langsjoen PH; Langsjoen PH; Folkers K: Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment. Clin Investig: 71:S140-4 (1993)

89. Langsjoen PH; Vadhanaviket S; Folkers K: Effective treatment with coenzyme Q10 of patients with myocardial disease classes III and IV. Biomed. and Clin.Aspects of CoQ10: 4:325-332 (1984)

90. Langsjoen PH; Willis R; Folkers K: Treatment of hypertrophic cardiomyopathy with coenzyme Q10. 9th Int. Symp. Biomed. and Clin. Asectsp of Coenzyme Q : 26 (1996)

91. Lewin A: The effect of coenzyme Q10 on sperm motility. 9th Intl.Symp.Biomed.and Clin.Aspects of Coenzyme Q: 9:47 (1996)

92. Linnane AW: The universality of bioenergetic disease, an amelioration therapy. coenzym Q 10 and analogues. 9th International Symp. on Biomed. and Clin. Aspects of Coenzym Q, Ancona, Italy, Institute of biochemistry, The Univerity of Ancona. (1996)

93. Littarru, Gian Paolo: Energie und Schutz - Coenzym Q10: Fakten und Perspektiven in der Biologie und Medizin: engl.Original: Casa Editrice Scientifica Internazionale, Rom, Italien; dt.Ausgabe zu beziehen bei: Intervalor Handels GmbH, Hochstr. 35-37, 60313 Frankfurt/Main
94. Lockwood K; Moesgaard S; Folkers K: Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10. Biochem Biophys Res Commun: 199:3:1504-1508 (1994)

95. Lockwood K; Moesgaard S; Hanioka T; Folkers K: Apparant partial remission of breast cancer in high-risk-patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol Aspects Med: 15s:231-240 (1994)

96. Lockwood K; Moesgaard S; Yamamoto T; Folkers K: Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Commun: 212:1:172-177 (1995)

97. Lodi R et al.: The use of phosphorus magnetic resonance spectroscopy to study in vivo the effect of coenzym Q10 treatment in retinitis pigmentosa. Molec.Aspects Med . Vol.15 (Supplement) 221-230 (1994)

98. Luft R The development of mitochondrial medicine. Proc.Natl. Acad.Sci., Vol. 91, pp. 8731-8738 (1994)

99. Mancini A; de Marinis L; Oradei A; Littarru GP; Conte G; Pozza D; Hallgass ME: Coenzyme Q10 concentrations in normal and pathological human seminal fluid . J Androl: 15:6:591-594 (1994)

100. Matsubara T; Yamagami T; Kishi T; Folkers K: Coenzyme Q10 hypertension, a 10-year survey. 8th Int. Symp. Biomed. and Clin.Aspects of CoQ10: 42 (1993)

101. Mellstedt H; Osterborg A; Nylander M; Morita M et al.: A deficiency of coenzyme Q10 in conventional cancer therapy and blood levels of CoQ10 in cancer patients in Sweden. 8th Int.Symp. Biomed. and Clin.Aspects of Co Q10: 47 (1993)

102. Meola G; Velicogna M; Bresolin N; Fortunato F; Moggio M; Scarlato G: Effects of CoQ10 on muscle Cells and skin fibroblast from patients with mitochondrial myopathies. Biomed.and clin.aspects of CoQ10: 6:383-396 (1991)

103. Michell B.: Oncogenes and inositol lipids. Nature 308:770 (1984)

104. Mohr D; Bowry VW; Stocker R: Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta: 1126:3:247-54 (1992)

105. Morisco C; Trimarco B, Condorelli M: Effect of Coenzyme Q10 therapy in patients with congestive heart failure: A long-term multicenter randomized study. Clin. Investig: 71:134-136 (1993)

106. Mortensen SA: Coenzyme Q10 and the diseased heart: blood and tissue levels of CoQ10 in relation to myocardial function and CoQ10 therapy. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 78-80 (1998)

107. Mortensen SA: Perspectives on therapy of cardiovascular diseases with CoQ10. Clin Investig: 71:S116-123 (1993)

108. Mortensen SA: Review of controlled double-blind trials with coenzyme Q10 (ubiqinone) in chronic heart failure and angina pectoris. 8th Int.Symp. Biomed. and Clin.Aspects of CoQ10 : 45 (1993)

109. Mortensen SA; Vadhanavakit S; Folkers R: Effectiveness of CoQ10 to treat patients with cardiomyopathy and CoQ10 levels in blood and endomyocardial biopsies. Biomed. and clin.aspects of CoQ10 : 4:391-402 (1984)

110. Mortensen S.A.: Perspectives on therapy of cardiovascular diseases with coenzym Q10 (Ubichinone). Clin. Investig. 71:116-123 (1993)

111. Müller U; Kriegelstein J: Sauerstoffradikalfänger als Neuroprotektiva. Dt. Apotheker Zeitung, Nr. 18, S.17 ff (1994)
112. Nishikawa Y et al.: Evaluations of long-term therapeutic effevtiveness of Coenzym Q10 on a case of Kearns-Sayre-syndrome. Biomed.and Clin.Aspects of Coenzyme Q, ed. by Folkers, K., Yamagani, T., Littarru, G.P., pp 375-382, Elsevier Science Publishers (1991)
113. Nobuyoshi M; Saito T; Takahira H; Kanazawa T et al.: Levels of CoQ10 in biopsies of left ventricular muscle and influence of administration of CoQ10 . Biomed. and Clin.Aspects of CoQ10: 4:221-230 (1984)

114. Nylander M; CoQ10: a therapeutic adjuvant in periodontal disease. 9th Intl.Symp.Biomed. and Clin.Aspects of Coenzyme Q: 9:41-42 (1996)

115. Nylander M; Malmsten N: A double blind dose-response study on effects of coenzyme Q10 on quality of life. Boston: 1st Conf. of the Intl. Coenzyme Q10 Assn .: 84 (1998)

116. Nylander M; Nordlund M: Response of periodontitis to therapy with coenzyme Q10. 8th Int.Symp. Biomed. and Clin.Aspects of CoQ10: 37 (1993)

117. Oda T: Dose-effect relationship and critical dose of coenzyme Q10 on load-induced cardiac dysfunction in pediatric patients with mitral valve prolapse . Biomed.and Clin.Aspects of CoQ10: 6:247 (1991)

118. Oda T: Q10 therapy on the cardiac dysfunction in patients with mitral valve prolapse: dose vs effect and dose vs serum Q10. Biomed. and Clin.Aspects of CoQ10: 5:269-280 (1986)

119. Oda T: Recovery of systolic time intervals by coenzyme Q10 in patients with load-induced cardiac dysfunction: echocardiographic study. 8th Int.Symp. Biomed. and Clin.Aspects of CoQ10: 27 (1993)

120. Ohlenschläger G: Das Vitaminoid Ubichinon (Co- emzym Q10) . Journal für orthomolekulare Medizin , 2. Jahrgang, Sept. 1994, Ausgabe 3/94: Ralf Reglin Verlag, Köln

121. Ohlenschläger G : Freie Radikale, Oxidativer Streß und Antioxidantien: Ralf Reglin Verlag, Köln

122. Ohlenschläger G: Komplexe radikalisch induzierte Kanzerogenese. Ein Hazardspiel?

123. Podda M; Packer L: Ubiquinol: a marker of oxidative stress in skin. 9th Intl.Symp.Biomed. and Clin.Aspects of Coenzyme Q10 : 9:43-44 (1996)

124. Praxis-telegramm Sonderbeilage (1993); 3-4, Juli.

125. Rajewsky M.F: Die Entstehung von Krebserkrankungen nach Einwirkung exogener und endogener Kanzerogene. Essener Unikate 1:7-21 (1992)

126. Rastogi SS; Singh RB; Shukla PK: Randomized, double-blind, placebo controlled trial of hydrosoluble coenzyme Q10 in patients with hyperinsulinemia. Boston: 1st Conf. of the Intl. Coenzyme Q10 Assn .: 118 (1998)

127. Richardson PC; Drzewoski J; Ellis JM; Folkers K; Shizukishi S; Takemura K; Baker L: Reduction of elevated blood pressure by coenzyme Q10. Biomed. and Clin.Aspects of CoQ10: 3:229-234 (1981)

128. Rosenfeldt FL; Pepe S; Ou R; Lew R; Madani J; Rowland MA; Nagley P; Linnane AW: Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress: studies in rats and in human atrial tissue. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 58-60 (1998)

129. Rusciani L; Oradei; Lippa; Littarru GP: CoQ10 levels in human light-exposed and unexposed skin . Biomed. and Clin.Aspects of Q10: 6:125-128 (1991)

130. Scaglione F; Lundstrom B; Barbieri B; Lund B: Coenzyme Q10 as an immunoenhancer: A single blind placebo and randomized clinical study. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 89-90 (1998)

131. Schnell O et al.: Zum Stellenwert neuer diagnostischer Ansätze bei der kardialen autonomen Neuropathie des Typ-I-Diabetikers. Diabetes und Stoffwechsel , 5, 127-134 (1996)

132. Schulz J.B. et al.: Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Exp.Neurol. 132, 279-283 (1995)

133. Schwab M; Ellison J; Busch M; Rosenau W; Varmus HE; Bishop JM: Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc. Natl. Acad. Sci. USA 81:4940-4944 (1984)

134. Shults CW; Haas RH; Beal MF: A possible role of coenzyme Q10 in the etiology and treatment of Parkinson´s disease. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 54-55 (1998)

135. Singh RB: New developments in the cardioprotective effects of coenzyme Q10. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 64 (1998)

136. Stocker R; Bowry VW; Frei B: Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol . Proc Natl Acad Sci USA : 88:5:1645-50 (1991)

137. Stocker R; Bowry VW; Suarna C; Umeda Y et al.: The role of ubiquinol-10 in the inhibition of radical-mediated low density lipoprotein oxidation. 8th Int.Symp. Biomed. and Clin.Aspects of CoQ10 : 20 (1993)

138. Sugimoto M; Ideta T; Imanishi K; Ono T et al.: Effect of CoQ10 in patients with progressive muscular dystrophy and other neuromuscular diseases . Biomed. and Clin.Aspects of CoQ10: 1:243-250 (1984)

139. Swedberg K; Hoffmann-Bang C; Rehnquist N; Aström H: Coenzyme Q10 as an adjunctive in treatment of congestive heart failure. 7th Intl. Symp.Biomed. and Clin.Aspects of CoQ10: A 15 (1992)

140. Syburra CA: Oxidative stress in patients with multiple sclerosis. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 125-126 (1998)

141. Syrkin A; Kogan A; Drynitsina S; Kuznetsov A; Pechorina E; Frenkel E: The effect of soluble form of Coenzyme Q10 on the oxygen free radical processes and clinical course in patients with coronary heart disease - stabile angina pectoris. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 110-111 (1998)

142. Takahashi N; Iwasaka T; Sugiura T; Onoyama H; Kurihara S; Inada M; Miki H; Uyama M: Effect of coenzym Q10 on hemidynamic response to ocular Timolol. J.Cardiovasc. Pharmacol. 14:462-468 (1989)

143. Tanaka J; Tominaga R; Yoshitoshi M; Mtsui K; Komori M; Sese A; Yasui H; Tokunaga K: Coenzyme Q10: the prophylactic effect on low cardiac output following cardiac valve replacement. Ann Thorac Surg: 33:2:145-51 (1982)

144. Trimarco B; Morisco C: Monitoring of hemodynamic response to exercise in patients with congestive heart failure: effects of CoQ10 therapy. 8th Int.Symp. Biomed. and Clin.Aspects of CoQ10: 35 (1993)

145. Valls V; Castelluccio C; Fato R; Genova ML; Bovina C; Saez G; Marchetti M; Castelli GP; Lenaz G: Protective effect of exogenous coenzyme Q against damage by Adriamycin in perfused rat liver. Biochem. Biomol. Biol. Int. 33, 4:633-642. (1994)

146. Van Gaal L; de Leeuw I; Vadhanavikit S; Folkers K: Exploratory study on Coenzyme Q10 in obesity . Biomed. and Clin.Aspects of CoQ10: 4:369-374 (1984)

147. Vanfraechem JHP; Picalausa C; Folkers K: Coenzyme Q10 and physical performance in myocardial Failure. Biomed. and Clin.Aspects of CoQ10: 4:281-290e (1984)

148. Vanfraechem JHP; Picalausa C; Folkers K: Effects of CoQ10 on physical performance and recovery in myocardial failure. Biomed. and Clin.Aspects of CoQ10 : 5:371-378 (1986)

149. Wander GS; Singh RB; Shukla PK: Randomized double blind trial of hydrosoluble Coenzyme Q10 in hypertensives with oxidative Stress and coronary artery: Boston. 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 144 (1998)

150. Weber M; Flor S; Heidenreich Y; Zernikow B; Menke T; Giffei J; Hennecke KH; Andler W: Maternal and neonatal coenzyme Q10 serum levels. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 75-76 (1998)

151. Weinberg RA: Molekulare Grundlagen von Krebs. Spektrum der Wissenschaft Jan.: 58-71 (1984)
152. Westermarck T; Antila E; Laakso J: Long-term-follow-up of a duchenne muscle dystrophy patient treated with antioxidants. 8th Int.Symp.Biomed. and Clin.Aspects of CoQ10: 74 (1993)
153. Williamson IR, Chang K, Allison W; Faller A; San- tiago JV; Tilton RH; Hasan KS: Increased blood flow in retina, sciatic nerve, and kidney in hyperglycemic nondiabetic rats. Diabetes 43: 1010-1014, (1994)

154. Wilson MF; Frishman WH; Giles T; Brackett DJ et al.: Coenzyme Q10 therapy and exercise duration in stable angina. Biomed. and Clin.Aspects of CoQ10: 6:339-348 (1991)

155. Wintersberger U: Onkogene. Funktionelle Pathologie: molekulare - zelluläre - systematische Grundlagen . Wick G; Schwarz S; Förster O; Peterlik M: Gustav Fischer Verlag Stuttgart, New York (1989)

156. Yamagami T; Shibata N; Folkers K: Bioenergetics in clinical medicine: VIII.Administration of coenzyme Q10 to patients with essential hypertension. Res Commun Chem Pathol Pharmacol: 14:4:721-7 (1976)

157. Yamagami T; Shibata N; Folkers K: Study of coenzyme Q10 in essential hypertension. Biomed. and Clin. Aspects of CoQ10: 4:231-242 (1984)

158. Yamagami T; Takagi M; Akagami H; Folkers K: Effect on Q10 on essential hypertension, a double blind controlled study. Biomed. and Clin.Aspects of CoQ10: 5:337-344 (1986)

159. Yamamoto Y; Yamashati S: Oxidative Stress in patients with liver and heart diseases evaluated by plasma ubiquinol/ubiquinone ratio. Boston: 1 st Conf. of the Intl. Coenzyme Q10 Assn.: 77 (1998)

160. Yamamoto Y; Yamashati S: Simultaneous detection of ubiquinone as a marker of oxidative stress. 9th Intl. Symp.Biomed. and Clin.Aspects of CoQ10 (1996)

161. Zilliken F: Eine klinische Doppelblind-Studie mit CoEnzym Q10 und Vitamin E bei herzkranken Patienten. De Orthomoleculaire Koerier: 5:24:4-11 (1990)

162. Zilliken F; Moritz J; Müller-Steinwachs J; Folkers et al: Double blind clinical study with Q10 in patients with low cardiac function. Biomed. and Clin.Aspects of Co Q10: 4:425-428 (1984)